Compare ARCT & DUOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARCT | DUOT |
|---|---|---|
| Founded | 2013 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 192.6M | 210.3M |
| IPO Year | N/A | N/A |
| Metric | ARCT | DUOT |
|---|---|---|
| Price | $7.55 | $9.54 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 1 |
| Target Price | ★ $38.44 | $14.00 |
| AVG Volume (30 Days) | ★ 510.7K | 224.4K |
| Earning Date | 03-05-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $97,601,000.00 | $19,026,308.00 |
| Revenue This Year | N/A | $286.66 |
| Revenue Next Year | N/A | $44.93 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 159.00 |
| 52 Week Low | $5.85 | $3.84 |
| 52 Week High | $24.17 | $12.17 |
| Indicator | ARCT | DUOT |
|---|---|---|
| Relative Strength Index (RSI) | 49.62 | 38.53 |
| Support Level | $7.00 | $8.26 |
| Resistance Level | $7.95 | $10.00 |
| Average True Range (ATR) | 0.37 | 0.73 |
| MACD | -0.02 | -0.27 |
| Stochastic Oscillator | 30.00 | 11.70 |
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains that are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.